By simultaneously targeting all three receptors, retatrutide is hypothesised to deliver additive effects on appetite suppression, insulin secretion, and energy expenditure
These formulations are also often described as being safe to consume, gentle on the stomach, and vegan
Ugyanakkor egyrtelm, hogy valami nincs rendben: a trtnelem legfejlettebb egszsggyi rendszere ll rendelkezsnkre, mgis millik halnak meg olyan betegsgekben, amelyeknek mr rgen nem kellene fenyegetst jelentenik

Activation of these receptors produces several effects: Appetite suppression: GLP-1 agonists activate anorexigenic (appetite-suppressing) POMC/CART neurons and inhibit orexigenic (appetite-stimulating) NPY/AgRP neurons in the hypothalamus, reducing hunger signaling Enhanced satiety: Activation of brainstem GLP-1 receptors amplifies satiety signals from the gastrointestinal tract, causing patients to feel full earlier and longer after meals Reduced food reward: GLP-1 receptor activation in the mesolimbic dopamine system reduces the hedonic drive to eat, diminishing cravings for high-calorie foods (Blundell et al., Diabetes, Obesity and Metabolism , 2017) Peripheral Effects Beyond central nervous system activity, GLP-1 agonists produce peripheral effects that contribute to weight loss: Delayed gastric emptying: GLP-1 receptor activation in the stomach slows gastric motility, prolonging gastric distension and promoting earlier satiety